Back to search results

Blood Recovery During Heart and Lung Surgeries

This study is comparing two ways to recover blood from surgical sponges during heart or lung surgery. One method is manually wringing sponges by hand, and the other uses an FDA-approved suction device called ProCell. Both methods are already used at University Hospitals. Researchers want to see which method is better at recovering blood efficiently and safely. You may be able to join if you are between 18 and 89 years old and are having certain heart or lung surgeries at University Hospitals Cleveland Medical Center. The study will look at the amount of blood recovered and how intact the red blood cells are with each method.

Study design
This study is an interventional study planning to enroll 20 participants. It compares two different methods of blood recovery.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Blood levels will be measured at the start of the study and again up to 120 minutes after processing.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05545930

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)

Recruiting
NAAges 18–89InterventionalSupportive care
University Hospitals Cleveland Medical Center
~20 participants
Updated 2026-01-07 on ClinicalTrials.gov
What's tested:Hand WrungProCell Wrung

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Level of Plasma Free Hemoglobin
Measured over Baseline
+2 more outcomes measured

Conditions

Blood Recovery

Explore related trials

Aortic SurgeryHeart TransplantationLung TransplantationMulti-valve RepairMulti-valve ReplacementRedo Sternotomy

Where it's being run

1 sites across 1 states
Ohio1

Study leadership

  • Rakesh Arora, MD · PRINCIPAL_INVESTIGATOR · University Hospitals Cleveland Medical Center

Who to contact

Jessica Hungate, MD
[email protected]
216-844-3800
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Undergoing heart or lung transplant, redo sternotomy, aortic surgery, and/or multi-valve repairs/replacements; and
At University Hospitals Cleveland Medical Center.

Exclusion

Patients with known bleeding disorders, including disseminated intravascular coagulation (DIC), prothrombin deficiency, factor V deficiency, factor VII deficiency, factor X deficiency, factor XI deficiency (hemophilia C), Glanzmann disease, hemophilia A, hemophilia B, idiopathic thrombocytopenic purpura (ITP), and Von Willebrand disease (types I, II, and III);
Patients undergoing emergent or emergent salvage surgery; and
Patients actively participating in another clinical trial which could affect outcomes.

What this trial measures

  • Level of Plasma Free HemoglobinBaseline

    Level of plasma free hemoglobin will be measured at baseline.

  • Level of Plasma Free HemoglobinPost-Processing (Up to 120 Minutes)

    Level of plasma free hemoglobin will be measured post-processing.

  • Change in Volume of BloodBaseline, Post-Processing (Up to 120 Minutes)

    Volume of blood will be measured at baseline and post-processing.